Affiliation:
1. Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas 77843
2. Center for Structural Biology, Institute of Biosciences and Technology, Texas A&M University System Health Science Center, Houston, Texas 77030
Abstract
ABSTRACT
β-Lactam antibiotics are extremely effective in disrupting the synthesis of the bacterial cell wall in both gram-positive and gram-negative bacteria. However, they are ineffective against
Mycobacterium tuberculosis
, due to the production of a β-lactamase enzyme encoded on the chromosome of
M. tuberculosis
that degrades these antibiotics. Indeed, recent studies have demonstrated that deletion of the
blaC
gene, the only gene encoding a β-lactamase in
M. tuberculosis
, or inhibition of the encoded enzyme resulted in significantly increased sensitivity to β-lactam antibiotics. In this paper we present a biochemical and structural characterization of
M. tuberculosis
BlaC. Recombinant BlaC shows a broad range of specificity with almost equal penicillinase and cepholothinase activity. While clavulanate is a mechanism-based inhibitor to class A β-lactamase with high potency (typically
K
i
< 0.1 μM), it is a relatively poor inhibitor of the
M. tuberculosis
BlaC (
K
i
= 2.4 μM). The crystal structure of the enzyme, determined at a resolution of 1.7 Å, shows that the overall fold of the
M. tuberculosis
enzyme is similar to other class A β-lactamases. There are, however, several distinct features of the active site, such as the amino acid substitutions N132G, R164A, R244A, and R276E, that explain the broad specificity of the enzyme, relatively low penicillinase activity, and resistance to clavulanate.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
131 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献